Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

RARE PHOTOS: Epizyme s return on capital employed insights | Vintage Vibes

According to Benzinga Pro data, during Q4, Epizyme (NASDAQ:EPZM) posted sales of $11.58 million. Earnings were up 23.06%, but Epizyme still reported an overall loss of $50.65 million. Epizyme collected $5.20 million in revenue during Q3, but reported earnings showed a $65.83 million loss.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.